Akari Therapeutics Plc Adr (AKTX)

Nov 26, 2025

Akari Therapeutics receives Nasdaq notice for minimum bid price non-compliance - Investing.com

Nov 26, 2025

Nov 26, 2025

Akari Therapeutics receives Nasdaq notice for minimum bid price non-compliance By Investing.com - Investing.com South Africa

Nov 26, 2025

Nov 25, 2025

Akari Therapeutics Announces Release of the Next CEO Corner Segment - Sahm

Nov 25, 2025

Nov 21, 2025

Tops & Flops Stocks - sharewise.com

Nov 21, 2025

Nov 18, 2025

Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer - Finviz

Nov 18, 2025

Nov 18, 2025

Akari Therapeutics appoints Kameel Farag as interim CFO By Investing.com - Investing.com South Africa

Nov 18, 2025

Nov 18, 2025

Akari Therapeutics appoints Kameel Farag as interim CFO - Investing.com

Nov 18, 2025

Nov 17, 2025

[DEF 14A] Akari Therapeutics Plc Definitive Proxy Statement - Stock Titan

Nov 17, 2025

Nov 17, 2025

[S-1] Akari Therapeutics Plc Files IPO Registration Statement | AKTX SEC FilingForm S-1 - Stock Titan

Nov 17, 2025

Nov 14, 2025

Insiders Re-Evaluate Their US$1.81m Stock Purchase As Akari Therapeutics Falls To US$19m - Sahm

Nov 14, 2025

Nov 10, 2025

Why Akari Therapeutics Plc Depositary Receipt stock appeals to analystsWall Street Watch & Verified Momentum Stock Watchlist - newser.com

Nov 10, 2025

Nov 07, 2025

[PRE 14A] Akari Therapeutics Plc Preliminary Proxy Statement - Stock Titan

Nov 07, 2025

Nov 06, 2025

Akari Therapeutics Plc ADR (AKTX) looking to reclaim success with recent performance - Setenews

Nov 06, 2025

Oct 30, 2025

Akari Therapeutics forms scientific advisory board with Dr. Hurvitz By Investing.com - Investing.com South Africa

Oct 30, 2025

Oct 30, 2025

Akari Therapeutics Announces Formation of Scientific Advisory Board and Inaugural Appointment of Renowned Medical Oncologist, Sara A. Hurvitz, MD, FACP - The Manila Times

Oct 30, 2025

Oct 30, 2025

AKTX SEC FilingsAkari Therapeutics Plc 10-K, 10-Q, 8-K Forms - Stock Titan

Oct 30, 2025

Oct 25, 2025

What Wall Street predicts for Akari Therapeutics Plc Depositary Receipt stock priceMarket Performance Summary & Weekly Breakout Stock Alerts - newser.com

Oct 25, 2025

Oct 23, 2025

Akari Therapeutics launches CEO Corner to enhance investor communications By Investing.com - Investing.com India

Oct 23, 2025

Oct 16, 2025

Form 424B5 Akari Therapeutics Plc - StreetInsider

Oct 16, 2025

Oct 15, 2025

Akari Therapeutics stock falls after $2.5 million registered offering - Investing.com

Oct 15, 2025

Oct 15, 2025

Akari Therapeutics secures $2.5 million through registered offering - Investing.com India

Oct 15, 2025

Oct 15, 2025

$2.5M raise: Akari Therapeutics to issue 3,125,000 ADSs in registered direct offering - Stock Titan

Oct 15, 2025

Oct 15, 2025

Akari Therapeutics stock falls after $2.5 million registered offering By Investing.com - Investing.com South Africa

Oct 15, 2025

Oct 09, 2025

Akari Therapeutics files new patents for cancer treatment technology - Investing.com India

Oct 09, 2025

Oct 09, 2025

Akari Therapeutics Files Two New Patents for Immuno-Oncology Mode of Action for Novel ADC Platform Utilizing Spliceosome Modulating Payload PH1 - Sahm

Oct 09, 2025

Oct 03, 2025

Morning Market Movers: DBVT, CLPT, DWTX, Seeing Big Swings - RTTNews

Oct 03, 2025

Oct 03, 2025

Will Akari Therapeutics Plc (Common Stock) (CLA) stock beat revenue estimatesWeekly Profit Analysis & Weekly Market Pulse Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Akari Therapeutics Announces Abstract Accepted for Oral Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting - Sahm

Oct 03, 2025

Sep 26, 2025

A new trading data show Core Scientific Inc (CORZ) is showing positive returns. - Setenews

Sep 26, 2025

Sep 25, 2025

Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews

Sep 25, 2025

Sep 24, 2025

Akari’s ADC payload shows promise against resistant prostate cancer By Investing.com - Investing.com South Africa

Sep 24, 2025

Sep 24, 2025

Akari’s ADC payload shows promise against resistant prostate cancer - Investing.com India

Sep 24, 2025

Sep 24, 2025

First Potential Treatment for AR-V7 Driven Prostate Cancer: Akari's PH1 Shows Dual Action in Studies - Stock Titan

Sep 24, 2025

Sep 22, 2025

Can momentum traders help lift Tripadvisor Inc.2025 Pullback Review & Verified Momentum Watchlists - newser.com

Sep 22, 2025

Sep 19, 2025

Analyzing PRA Group Inc. with risk reward ratio chartsJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com

Sep 19, 2025

Sep 19, 2025

Institutional scanner results for ANSYS Inc.Entry Point & Verified Technical Trade Signals - newser.com

Sep 19, 2025

Sep 19, 2025

Does SRTY fit your quant trading modelPortfolio Gains Report & Stock Timing and Entry Methods - newser.com

Sep 19, 2025

Sep 17, 2025

Akari Therapeutics files patent for novel cancer treatment approach By Investing.com - Investing.com South Africa

Sep 17, 2025

Sep 17, 2025

Akari Therapeutics files patent for novel cancer treatment approach - Investing.com

Sep 17, 2025

Sep 17, 2025

Revolutionary Spliceosome Cancer Treatment: Akari Files Patent for First-in-Class ADC Platform Technology - Stock Titan

Sep 17, 2025

Sep 16, 2025

Is BSIIU stock reversal real or fake2025 Market Overview & Verified Swing Trading Watchlists - newser.com

Sep 16, 2025

Sep 14, 2025

Security Solutions Inc.2025 Market Outlook & Smart Money Movement Tracker - newser.com

Sep 14, 2025

Sep 14, 2025

Applying big data sentiment scoring on HLITJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com

Sep 14, 2025

Sep 05, 2025

Novel ADC Developer Akari Therapeutics to Showcase Pipeline at Major Healthcare Conference - Stock Titan

Sep 05, 2025

Sep 03, 2025

Next-Gen Cancer Drug Developer Akari Therapeutics Showcases Novel IO-Payload ADC Platform - Stock Titan

Sep 03, 2025

Aug 30, 2025

Advanced analytics toolkit walkthrough for Educational Development CorporationShare Buyback & Free Expert Approved Momentum Trade Ideas - Newser

Aug 30, 2025

Aug 29, 2025

What high frequency data says about MGTXOil Prices & Free Technical Confirmation Trade Alerts - Newser

Aug 29, 2025

Aug 28, 2025

Using AI based signals to follow BWXT2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser

Aug 28, 2025

Aug 28, 2025

Analyzing recovery setups for Guardian Pharmacy Services Inc. investorsMarket Volume Report & Weekly High Return Stock Forecasts - Newser

Aug 28, 2025

Aug 21, 2025

Akari Therapeutics completes $2.8 million note offering and extends warrant terms - Investing.com

Aug 21, 2025

Aug 19, 2025

Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan

Aug 19, 2025

Aug 14, 2025

Cancer Drug Developer Akari Therapeutics Showcases Pipeline at Webull Biotech Conference - Stock Titan

Aug 14, 2025

Aug 09, 2025

Is BACQR still worth holding after the dipEquity Market Return Forecast Model Update - Newser

Aug 09, 2025

Jul 31, 2025

Insider Stock Buying Reaches US$1.79m On Akari Therapeutics - Sahm

Jul 31, 2025

Jul 29, 2025

Akari Therapeutics Reveals Breakthrough Progress in Cancer-Fighting Drug Development - Stock Titan

Jul 29, 2025